CAS 1707289-21-1

BLU-554

CAS: 1707289-21-1

Formel: C₂₄H₂₄Cl₂N₄O₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 503.3778

Ref: IN-DA00AMH4

N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-Dimethoxyphenyl)Quinazolin-2-Yl)Amino)Tetrahydro-2H-Pyran-4-Yl)Acrylamide

CAS: 1707289-21-1

N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-Dimethoxyphenyl)Quinazolin-2-Yl)Amino)Tetrahydro-2H-Pyran-4-Yl)Acrylamide

Reinheit: 97%

Molekulargewicht: 503.38g/mol

Ref: 54-OR1025917

Fisogatinib

CAS: 1707289-21-1

Fisogatinib

Reinheit: ≥95%

Molekulargewicht: 503.38g/mol

Ref: 54-BUP12180

Fisogatinib

CAS: 1707289-21-1

Fisogatinib (BLU-554) is a highly potent, selective, and orally active FGFR4 inhibitor.Cost-effective and quality-assured.

Formel: C₂₄H₂₄Cl₂N₄O₄

Reinheit: 99.27% - ≥95%

Farbe und Form: Solid

Molekulargewicht: 503.38

Ref: TM-T3456

BLU 554

CAS: 1707289-21-1

A potent and selective covalent inhibitor of fibroblast growth factor receptor 4 (FGFR4). This receptor tyrosine kinase activates an oncogenic driver in hepatocellular carcinoma, the fibroblast growth factor 19 (FGF19). The FGFR4 inhibitor is therefore a promising candidate for the treatment of advanced liver cancer.

Formel: C₂₄H₂₄Cl₂N₄O₄

Reinheit: Min. 95%

Farbe und Form: White Powder

Molekulargewicht: 503.38 g/mol

Ref: 3D-BB160379